<DOC>
	<DOCNO>NCT01754688</DOCNO>
	<brief_summary>The investigator hypothesize new BIND ( Bilirubin Induced Neurologic Dysfunction ) score method adapt develop world ( BIND II , develop team use health care worker ) , additional modification community use ( community BIND , C-BIND ) , improve ability identify infant ABE distinguish ABE common cause neonatal morbidity mortality compare currently available survey tool .</brief_summary>
	<brief_title>Determining Prevalence Acute Bilirubin Encephalopathy Developing Countries</brief_title>
	<detailed_description />
	<mesh_term>Brain Diseases</mesh_term>
	<mesh_term>Kernicterus</mesh_term>
	<mesh_term>Bilirubin</mesh_term>
	<criteria>Subjects eligible participate study follow condition exist : 1 . At time birth , neonates ≥ 35 week gestational age ≥ 2250 grams gestational age unavailable . 2 . ≤ 14 day old 3 . Parent guardian give consent infant participate 1 . Infants condition require urgent referral another facility treatment available hospital study site . 2 . Infants admit surgical procedure without underlie medical illness . 3 . Infants condition require blood draw treatment problem reason blood draw would study enrollment .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>14 Days</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>